RIT-RISE Scientists-in-Training Series: Modifying Brain Inflammatory Responses to Treat Alzheimer's Disease
Event Image
The inflammatory response characteristic of Alzheimer’s disease (AD) has been identified as a major driver of brain injury, however current work suggests a more nuanced role with both positive and negative outcomes. Dr. O’Banion will promote the “positive” benefits of inflammation with a long-term goal of identifying new therapeutic targets.
Contact
Kit Kenyon
Event Snapshot
When and Where
May 04, 2021
2:00 pm - 3:00 pm
Room/Location: Zoom
Who
Open to the Public
| Cost | FREE |
Interpreter Requested?
Yes
Topics
deaf community
diversity
research